but i bet she doesnt liek him for his penis either afte rthat, casue if we all know that she aint savin his penis for him then she w ohthatswhoimdealingwiththesouthernONLYWAYOADMITIMNOTRACISTWHITETRASHNONTHINKERSTHATTHEYTHEbLACKPOEPLETHEYFUCKALWAYSTALKABOUT
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer GeneticsThe deal is a dramatic bet that the London-based drug giant can see opportunities connected to the genetics of cancer drugs better than the stock market. It fits into a framework outlined in July by Hal Barron, the widely respected pharma veteran who took over as GSK’s head of R&D last year.
Source: Forbes - 🏆 394. / 53 Read more »
GSK slides after buying cancer firm Tesaro for hefty $5.1 billionGlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion... Fear of Death Sells :) PARP PARP
Source: Reuters - 🏆 2. / 97 Read more »
GSK to buy cancer drugmaker Tesaro for $5.1 billionGlaxoSmithKline has agreed to buy U.S. cancer drug specialist Tesaro for $5.1 bi... Time to bring insulin production to the U.K.
Source: Reuters - 🏆 2. / 97 Read more »
Pharma giant GSK just made a $5.1 billion bet on a cancer drugmakerPharma giant GlaxoSmithKline just acquired cancer drugmaker Tesaro for $5.1 billion in a bid to bulk up its cancer pipeline.
Source: BusinessInsider - 🏆 729. / 51 Read more »
GSK looks like a better seller than buyerThe UK drug giant is acquiring cancer specialist Tesaro for $5.1 bln and offloading its Horlicks unit to Unilever for about the same amount. It’s a neat way for CEO Emma Walmsley to reshape GSK. But the purchase will take years to pay off – and is much riskier than hot drinks.
Source: Breakingviews - 🏆 470. / 51 Read more »